Mladen Belicza
- Co-authors
- Božo KrušlinDavor TomasMato VukelićBranko ŠoštarićHrvoje ČupićDavor SolterIvan DamjanovN. Škreb
- Topics
- Nonmelanoma Skin Cancer Studies (7 papers)Renal cell carcinoma treatment (6 papers)Prostate Cancer Diagnosis and Treatment (5 papers)
- Cited by
- Cancer ResearchOncologyDermatology
- Partner nations
- CroatiaAustriaSwitzerland
In The Last Decade
Mladen Belicza
52 papers receiving 500 citations
Peers
Comparison fields: 5 of 73
- Molecular Biology 128
- Pulmonary and Respiratory Medicine 126
- Oncology 119
- Surgery 100
- Epidemiology 97
Countries citing papers authored by Mladen Belicza
This map shows the geographic impact of Mladen Belicza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mladen Belicza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mladen Belicza more than expected).
Fields of papers citing papers by Mladen Belicza
This network shows the impact of papers produced by Mladen Belicza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mladen Belicza. The network helps show where Mladen Belicza may publish in the future.
Co-authorship network of co-authors of Mladen Belicza
This figure shows the co-authorship network connecting the top 25 collaborators of Mladen Belicza. A scholar is included among the top collaborators of Mladen Belicza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mladen Belicza. Mladen Belicza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Apoptotic markers (P53, Bcl-2 and Bax) expression in renal oncocytoma and chromophobe renal cell carcinoma | 1 |
| 2 | (Expression of bcl-2, Ki-67 and p-53 protein in pT2 and pT3 invasion stages of uveal melanomas) | 1 |
| 3 | 1 | |
| 4 | Uloga kvasaca u infekciji rane dijabetičkog stopala | 1 |
| 5 | 13 | |
| 6 | [Role of yeasts in diabetic foot ulcer infection]. | 16 |
| 7 | 31 | |
| 8 | 28 | |
| 9 | Candida infections of diabetic foot ulcers | 23 |
| 10 | 2 | |
| 11 | Sudden cardiac death due to physical exercise in male competitive athletes. A report of six cases. | 8 |
| 12 | 21 | |
| 13 | [Change in the occurrence of breast cancer in hospital registries (1980-2000)]. | 3 |
| 14 | COLLECTING DUCT CARCINOMA OF THE KIDNEY: REPORT OF THREE CASES * | 4 |
| 15 | METASTATIC MELANOMA IN BIOPSY MATERIAL IN THE 1995-2000 PERIOD* | 1 |
| 16 | 2 | |
| 17 | 12 | |
| 18 | 45 | |
| 19 | 50 | |
| 20 | Interferon therapy for basal cell carcinoma and squamous cell carcinoma. | 13 |
About Mladen Belicza
Mladen Belicza is a scholar working on Oncology, Urology and Immunology and Allergy, having authored 58 papers that have together received 542 indexed citations. Recurring topics across this work include Nonmelanoma Skin Cancer Studies (7 papers), Renal cell carcinoma treatment (6 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). The work is most often cited by research in Cancer Research (71 citations), Oncology (119 citations) and Dermatology (38 citations). Mladen Belicza has collaborated with scholars based in Croatia, Austria and Switzerland. Frequent co-authors include Božo Krušlin, Davor Tomas, Mato Vukelić, Branko Šoštarić, Hrvoje Čupić, Davor Solter, Ivan Damjanov, N. Škreb, Ognjen Kraus and Gregor Mikuz. Their work appears in journals such as JNCI Journal of the National Cancer Institute, European Urology and The Journal of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.